ATE82502T1 - Zusammensetzungen zur vorbeugung von plastikabstossung. - Google Patents

Zusammensetzungen zur vorbeugung von plastikabstossung.

Info

Publication number: ATE82502T1
Authority: AT; Austria
Prior art keywords: rejection; heparin; compositions; humans; preventing plastic
Prior art date: 1986-06-26

Application number

AT87108976T

Other languages

English (en)

Inventor

Irun Cohen

Israel Vlodavsky

Amiram Eldor

Yaakov Naparstek

Original Assignee

Hadassah Med Org

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-06-26

Filing date

1987-06-23

Publication date

1992-12-15

1987-06-23 Application filed by Hadassah Med Org, Yeda Res & Dev filed Critical Hadassah Med Org

1992-12-15 Application granted granted Critical

1992-12-15 Publication of ATE82502T1 publication Critical patent/ATE82502T1/de

Links

239000000203 mixture Substances 0.000 title 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 3
229960002897 heparin Drugs 0.000 abstract 2
229920000669 heparin Polymers 0.000 abstract 2
208000023275 Autoimmune disease Diseases 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
230000002429 anti-coagulating effect Effects 0.000 abstract 1
239000003146 anticoagulant agent Substances 0.000 abstract 1
229940127219 anticoagulant drug Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Transplantation (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)
Materials For Medical Uses (AREA)
Soil Working Implements (AREA)
Paper (AREA)
Fertilizers (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT87108976T 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastikabstossung. ATE82502T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL79254A IL79254A0 (en)	1986-06-26	1986-06-26	Compositions for preventing graft rejection
EP87108976A EP0251134B1 (de)	1986-06-26	1987-06-23	Zusammensetzungen zur Vorbeugung von Plastik-Abstossung

Publications (1)

Publication Number	Publication Date
ATE82502T1 true ATE82502T1 (de)	1992-12-15

Family

ID=11056896

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87108976T ATE82502T1 (de)	1986-06-26	1987-06-23	Zusammensetzungen zur vorbeugung von plastikabstossung.

Country Status (10)

Country	Link
EP (1)	EP0251134B1 (de)
JP (1)	JP2527749B2 (de)
AT (1)	ATE82502T1 (de)
AU (1)	AU608228B2 (de)
DE (1)	DE3782686T2 (de)
DK (1)	DK169422B1 (de)
ES (1)	ES2052514T3 (de)
GR (1)	GR3006814T3 (de)
IL (1)	IL79254A0 (de)
NO (1)	NO872675L (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5541166A (en) *	1987-01-23	1996-07-30	The Australian National University	Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
IL85145A (en) *	1987-01-23	1994-08-26	Univ Australian	Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
GB8808810D0 (en) *	1988-04-14	1988-05-18	Biopharm Clinical Research Ltd	Heparin-containing formulations
IL86753A0 (en) *	1988-06-15	1988-11-30	Hadassah Med Org	Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) *	1988-06-23	1989-12-28	Solco Basel Ag	Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) *	1988-12-01	1989-07-31	Hadassah Med Org	Compositions containing a compound binding to a heparin receptor
US5158940A (en) *	1990-02-14	1992-10-27	The United States Government As Represented By The Secretary, Dhhs	Use of suramin to treat rheumatologic diseases
WO1999003493A1 (en) *	1997-07-14	1999-01-28	Meiji Milk Products Co., Ltd.	Drugs containing as the active ingredient midkine or inhibitors thereof
US6538028B1 (en)	2000-02-01	2003-03-25	Vanderbilt University	Method for inhibiting complement activation
CN1197587C (zh) *	2000-06-09	2005-04-20	中国科学院上海细胞生物学研究所	N－位脱硫酸肝素在预防和治疗炎症中的应用
CZ307433B6 (cs)	2001-09-12	2018-08-22	Leadiant Biosciences Sa	Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
ES2399277T3 (es)	2004-05-27	2013-03-27	Baxter International Inc.	Procedimiento de tratamiento de trastornos hemorrágicos utilizando polisacáridos sulfatados
WO2010020423A2 (en)	2008-08-22	2010-02-25	Baxter Healthcare S.A.	Methods for treating bleeding disorders
JP6393453B2 (ja)	2010-01-14	2018-09-19	バクスアルタゲーエムベーハー	出血性障害を治療するための方法及び組成物
EP2734213B1 (de)	2011-07-19	2018-06-06	Baxalta GmbH	Resorptionsförderer als additive zur verbesserung der oralen formulierung nicht-antikoagulierender sulfatierter polysaccharide
EP2885642B1 (de)	2012-08-14	2019-05-15	Baxalta GmbH	Verfahren und systeme zum screening von zusammensetzungen mit nicht gerinnenden sulfatierten polysacchariden
EP3578184A1 (de)	2013-03-12	2019-12-11	Baxalta GmbH	Resorptionsförderer als additive zur verbesserung der oralen formulierung von niedermolekularen heparinen
SE538503C2 (en)	2014-11-11	2016-08-16	Tx Medic Ab	New dextran sulfate
WO2016198578A1 (en) *	2015-06-11	2016-12-15	Universiteit Maastricht	Method for preventing transplant failure in a host.
JP2025516366A (ja) *	2022-05-06	2025-05-27	バージェントセラピューティクスプロプライエタリーリミテッド	同種移植拒絶反応の治療方法

1986
- 1986-06-26 IL IL79254A patent/IL79254A0/xx unknown
1987
- 1987-06-23 EP EP87108976A patent/EP0251134B1/de not_active Expired - Lifetime
- 1987-06-23 AT AT87108976T patent/ATE82502T1/de not_active IP Right Cessation
- 1987-06-23 ES ES87108976T patent/ES2052514T3/es not_active Expired - Lifetime
- 1987-06-23 DE DE8787108976T patent/DE3782686T2/de not_active Expired - Fee Related
- 1987-06-25 AU AU74706/87A patent/AU608228B2/en not_active Ceased
- 1987-06-25 NO NO872675A patent/NO872675L/no unknown
- 1987-06-26 DK DK331287A patent/DK169422B1/da not_active IP Right Cessation
- 1987-06-26 JP JP62159514A patent/JP2527749B2/ja not_active Expired - Lifetime
1993
- 1993-01-14 GR GR930400069T patent/GR3006814T3/el unknown

Also Published As

Publication number	Publication date
DE3782686T2 (de)	1993-06-09
ES2052514T3 (es)	1994-07-16
NO872675D0 (no)	1987-06-25
JPS6388127A (ja)	1988-04-19
JP2527749B2 (ja)	1996-08-28
AU608228B2 (en)	1991-03-28
DK169422B1 (da)	1994-10-31
NO872675L (no)	1987-12-28
GR3006814T3 (de)	1993-06-30
IL79254A0 (en)	1986-09-30
DK331287A (da)	1987-12-27
EP0251134A2 (de)	1988-01-07
DE3782686D1 (de)	1992-12-24
AU7470687A (en)	1988-01-07
EP0251134A3 (en)	1989-05-03
DK331287D0 (da)	1987-06-26
EP0251134B1 (de)	1992-11-19

Similar Documents

Publication	Publication Date	Title
ATE82502T1 (de)	1992-12-15	Zusammensetzungen zur vorbeugung von plastikabstossung.
DE3587266D1 (de)	1993-05-19	Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ATE122542T1 (de)	1995-06-15	Essbare plastische dispersion.
ATE190496T1 (de)	2000-04-15	Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
DE10199020I2 (de)	2004-05-06	Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ATE60924T1 (de)	1991-03-15	Verfahren zur kontrollierten herstellung von glykosaminoglykanen mit niedrigem molekulargewicht.
ES2001707A6 (es)	1988-06-01	Un procedimiento para preparar una sustancia anticoagulante de placenta humana
DE69328438D1 (de)	2000-05-25	Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung
ES2137225T3 (es)	1999-12-16	Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
ES2070116T3 (es)	1995-06-01	Peptidos que inhiben la union del factor von willebrand.
DE3584560D1 (de)	1991-12-05	Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE69027220D1 (de)	1996-07-04	Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
EP0376251A3 (en)	1990-12-19	An anticoagulant substance obtained from urine
ATE113591T1 (de)	1994-11-15	4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
FI873429A7 (fi)	1988-02-19	Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
SE8802193L (sv)	1989-02-08	Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
DE69919578D1 (de)	2004-09-23	VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
ATE70444T1 (de)	1992-01-15	Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ES2062754T3 (es)	1994-12-16	Eliminacion de linfocitos activados.
ATE96039T1 (de)	1993-11-15	Arzneimittel und ihre verwendung zur behandlung von parasitosen.
DK0515550T3 (da)	1998-02-02	Heparinneutralisation med blodpladefaktor 4
DE68904195D1 (de)	1993-02-11	Paromomycin oder seine derivate zur parenteralen behandlung von parasitaeren erkrankungen beim menschen.
IT8919204A0 (it)	1989-01-26	Composizione per la prevenzione e la cura di parodontopatte.
ATE55252T1 (de)	1990-08-15	Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.

Legal Events

Date	Code	Title
1993-04-15	EEIH	Change in the person of patent owner
1993-07-15	UEP	Publication of translation of european patent specification
1999-03-15	REN	Ceased due to non-payment of the annual fee